Norway’s Crown Princess Mette-Marit: Renewed treatment for lung disease

Norway’s Crown Princess Mette-Marit
Re-treatment for lung disease

Mette-Marit went public with her illness in 2018.

Mette-Marit went public with her illness in 2018.

© ddp/DPPA

Incurable pulmonary fibrosis: Norwegian Crown Princess Mette-Marit has sought treatment again for her lung disease.

Crown Princess Mette-Marit (51) is once again causing concern with her health. Years ago, the wife of the Norwegian heir to the throne Haakon (51) was diagnosed with chronic pulmonary fibrosis. In the past, the incurable lung disease made it impossible for her to fulfill her royal duties for weeks at a time. She is now being treated again, as the Norwegian court announced in an official statement.

“Her Royal Highness, Crown Princess Mette-Marit, has resumed treatment for her chronic lung disease,” it said on October 11 published statement. This information is being shared with the public because “previous experience” has shown “that the medication can lead to side effects that can have an impact on the Crown Princess’ official program.” The palace will keep the people informed about changes in the calendar.

Mette-Marit deals openly with the illness

Mette-Marit went public with her illness in 2018 and has since spoken about her poor health in several interviews. She has to slow down because of her lungs, but tries not to let it limit her too much. For example, she had to miss the 50th anniversary of Sweden’s King Carl Gustaf (78) in September 2023.

In pulmonary fibrosis, the connective tissue of the lungs is damaged by inflammatory processes and changes. This leads to impaired lung function, meaning oxygen is absorbed less effectively. The most common symptoms include shortness of breath, cough and shortness of breath.

SpotOnNews

source site-8

Related Articles